Literature DB >> 1376918

Phosphorylation-dependent epitopes of neurofilament antibodies on tau protein and relationship with Alzheimer tau.

B Lichtenberg-Kraag1, E M Mandelkow, J Biernat, B Steiner, C Schröter, N Gustke, H E Meyer, E Mandelkow.   

Abstract

We have studied the phosphorylation of tau protein from Alzheimer paired helical filaments, of tau from normal human brain, and of recombinant tau isoforms. As a tool we used monoclonal antibodies against neurofilament protein [Sternberger, N., Sternberger, L. & Ulrich, J. (1985) Proc. Natl. Acad. Sci. USA 82, 4274-4276] that crossreact with tau in a phosphorylation-dependent manner. This allowed us to deduce the state of phosphorylation in normal and pathological tau, as well as antibody epitopes. The epitope of antibody SMI33 is at the first Lys-Ser-Pro sequence motif (residues 234-236) and requires an unphosphorylated Ser-235. Antibody SMI31 binds between Ser-396 (in the second Lys-Ser-Pro motif) and Ser-404, both of which must be phosphorylated. SMI34 has a conformational epitope that depends on the interaction between regions on either side of the microtubule-binding region; it also requires phosphorylation. The phosphorylatable serines detected by the SMI antibodies are part of Ser-Pro motifs and can be phosphorylated by a protein kinase activity that can be used to induce a paired helical filament-like state in human brain tau in vitro. The phosphates are incorporated in several stages that can be identified by antibody reactivity and gel shift. This suggests a role for the phosphorylation sites in Alzheimer disease, as well as the involvement of a Ser-Pro-directed protein kinase.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1376918      PMCID: PMC49296          DOI: 10.1073/pnas.89.12.5384

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Abnormal processing of multiple proteins in Alzheimer disease.

Authors:  H Zhang; N H Sternberger; L J Rubinstein; M M Herman; L I Binder; L A Sternberger
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

2.  Use of T7 RNA polymerase to direct expression of cloned genes.

Authors:  F W Studier; A H Rosenberg; J J Dunn; J W Dubendorff
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

3.  A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis.

Authors:  S G Greenberg; P Davies
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

4.  Abnormal phosphorylation of tau precedes ubiquitination in neurofibrillary pathology of Alzheimer disease.

Authors:  C Bancher; I Grundke-Iqbal; K Iqbal; V A Fried; H T Smith; H M Wisniewski
Journal:  Brain Res       Date:  1991-01-18       Impact factor: 3.252

5.  Phosphate-dependent monoclonal antibodies to neurofilaments and Alzheimer neurofibrillary tangles recognize a synthetic phosphopeptide.

Authors:  M P Coleman; B H Anderton
Journal:  J Neurochem       Date:  1990-05       Impact factor: 5.372

6.  Phosphorylation of tau proteins to a state like that in Alzheimer's brain is catalyzed by a calcium/calmodulin-dependent kinase and modulated by phospholipids.

Authors:  J Baudier; R D Cole
Journal:  J Biol Chem       Date:  1987-12-25       Impact factor: 5.157

7.  Recognition of tau epitopes by anti-neurofilament antibodies that bind to Alzheimer neurofibrillary tangles.

Authors:  H Ksiezak-Reding; D W Dickson; P Davies; S H Yen
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

8.  Epitopes that span the tau molecule are shared with paired helical filaments.

Authors:  K S Kosik; L D Orecchio; L Binder; J Q Trojanowski; V M Lee; G Lee
Journal:  Neuron       Date:  1988-11       Impact factor: 17.173

9.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease.

Authors:  M Goedert; M G Spillantini; R Jakes; D Rutherford; R A Crowther
Journal:  Neuron       Date:  1989-10       Impact factor: 17.173

10.  Tau protein becomes long and stiff upon phosphorylation: correlation between paracrystalline structure and degree of phosphorylation.

Authors:  T Hagestedt; B Lichtenberg; H Wille; E M Mandelkow; E Mandelkow
Journal:  J Cell Biol       Date:  1989-10       Impact factor: 10.539

View more
  41 in total

1.  Analysis of intracytoplasmic hyaline bodies in a hepatocellular carcinoma. Demonstration of p62 as major constituent.

Authors:  C Stumptner; H Heid; A Fuchsbichler; H Hauser; H J Mischinger; K Zatloukal; H Denk
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

2.  Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease.

Authors:  E B Mukaetova-Ladinska; F Garcia-Siera; J Hurt; H J Gertz; J H Xuereb; R Hills; C Brayne; F A Huppert; E S Paykel; M McGee; R Jakes; W G Honer; C R Harrington; C M Wischik
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

3.  Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau.

Authors:  D N Drechsel; A A Hyman; M H Cobb; M W Kirschner
Journal:  Mol Biol Cell       Date:  1992-10       Impact factor: 4.138

4.  Selective interaction of lansoprazole and astemizole with tau polymers: potential new clinical use in diagnosis of Alzheimer's disease.

Authors:  Leonel E Rojo; Jans Alzate-Morales; Iván N Saavedra; Peter Davies; Ricardo B Maccioni
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

5.  Novel diffusion barrier for axonal retention of Tau in neurons and its failure in neurodegeneration.

Authors:  Xiaoyu Li; Yatender Kumar; Hans Zempel; Eva-Maria Mandelkow; Jacek Biernat; Eckhard Mandelkow
Journal:  EMBO J       Date:  2011-10-18       Impact factor: 11.598

6.  Characterization of a shared epitope in cortical Lewy body fibrils and Alzheimer paired helical filaments.

Authors:  M S Pollanen; C Bergeron; L Weyer
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

7.  A truncated peptide from p35, a Cdk5 activator, prevents Alzheimer's disease phenotypes in model mice.

Authors:  Varsha Shukla; Ya-Li Zheng; Santosh K Mishra; Niranjana D Amin; Joseph Steiner; Philip Grant; Sashi Kesavapany; Harish C Pant
Journal:  FASEB J       Date:  2012-10-04       Impact factor: 5.191

8.  The role of tau phosphorylation in transfected COS-1 cells.

Authors:  M Medina; E Montejo de Garcini; J Avila
Journal:  Mol Cell Biochem       Date:  1995-07-05       Impact factor: 3.396

9.  Comparison of the phosphorylation of microtubule-associated protein tau by non-proline dependent protein kinases.

Authors:  T J Singh; I Grundke-Iqbal; B McDonald; K Iqbal
Journal:  Mol Cell Biochem       Date:  1994-02-23       Impact factor: 3.396

10.  Kidins220/ARMS modulates the activity of microtubule-regulating proteins and controls neuronal polarity and development.

Authors:  Alonso M Higuero; Lucía Sánchez-Ruiloba; Laura E Doglio; Francisco Portillo; José Abad-Rodríguez; Carlos G Dotti; Teresa Iglesias
Journal:  J Biol Chem       Date:  2009-11-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.